References
- Chan JKC, Quintanilla-Martinez L, Ferry JA, . Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, , editors. World Health Organization classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 285–288.
- Yu JB, Zuo Z, Tang Y, . Extranodal nasal-type natural killer/ T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China. Hum Pathol 2009;6:807–816.
- Kiely JM, Massey BD Jr, Harrison EG Jr, . Lymphoma of the testis. Cancer 1970;4:847–852.
- Al-Abbadi MA, Hattab EM, Tarawneh M, . Primary testicular and paratesticular lymphoma: a retrospective clinicopathologic study of 34 cases with emphasis on differential diagnosis. Arch Pathol Lab Med 2007;7:1040–1046.
- Sun T, Brody J, Susin M, . Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity. Am J Surg Pathol 1993;12:1289–1299.
- Chan JK, Tsang WY, Lau WH, . Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 1996;6:1198–1205.
- Chan JK, Sin VC, Wong KF, . Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;12:4501–4513.
- Güler G, Altinok G, Uner AH, . CD56 + lymphoma presenting as a testicular tumor. Leuk Lymphoma 1999;36:207–211.
- Pérez-Vallés A, Sabater-Marco V, Carpio-Máñez D, . Extranodal peripheral T-cell lymphoma with angiocentric growth pattern and Epstein-Barr viral DNA associated affecting paratesticular soft tissue. Cutan Pathol 2000;2:80–86.
- Totonchi KF, Engel G, Weisenberg E, . Testicular natural killer/T-cell lymphoma, nasal type, of true natural killer-cell origin. Arch Pathol Lab Med 2002;12:1527–1529.
- Kim YB, Chang SK, Yang WI, . Primary NK/T cell lymphoma of the testis. A case report and review of the literature. Acta Haematol 2003;2:95–100.
- Ko YH, Cho EY, Kim JE, . NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology 2004;5:480–489.
- Ng SB, Lai KW, Murugaya S, . Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004;9:1097–1107.
- Ballereau C, Leroy X, Morschhauser F, . Testicular natural killer T-cell lymphoma. Int J Urol 2005;2:223–224.
- Zeng QB, Cheng FJ, Gao QP, . Primary NK/T cell lymphoma of the testis: a case report and review of the literature. Chin-Germ J Clin Oncol 2007;6:596–600.
- Ornstein DL, Bifulco CB, Braddock DT, . Histopathologic and molecular aspects of CD56 + natural killer/ T-cell lymphoma of the testis. Int J Surg Pathol 2008;3:291–300.
- Matsuda M, Iwanaga T, Hashimoto S, . Primary Epstein-Barr virus-negative nasal-type natural killer/T cell lymphoma of the testis. Leuk Res 2009;8:e119–e120.
- Ayadi L, Makni S, Toumi N, . Aggressive nasal-type natural killer/T-cell lymphoma associated with Epstein Barr virus presenting as testicular tumor. Tunis Med 2010;3:196–198.
- Wright CA, Cooper K, Leiman G, . Natural killer cell lymphoma in cytology: breaking all the rules—a case report. Diagn Cytopathol 1998;1:9–11.
- Bartolomé J, González-Arenas MC, Menárguez J, . Nasal type T/NK cell lymphoma with testicular presentation. Med Clin (Barc) 2000;8:318.
- Kurpis M, Diller AB, Calafat P, . Extranodal NK/T cell lymphoma of the nasal type. Rev Fac Cien Med Univ Nac Cordoba 2002;1:117–120.
- Morelli L, Piscioli I, Licci S, . T/natural killer-cell lymphoma of the testis with cutaneous and subcutaneous soft tissue involvement: a management problem. Ann Hematol 2007;6:469–470.
- A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;14:987–994.
- van Dongen JJ, Langerak AW, Brüggemann M, . Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;12:2257–2317.
- Brüggemann M, White H, Gaulard P, . Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia 2007;2:215–221.
- Zouhair A, Herrmann E, Ugurluer G, . Primary testicular lymphoma. Swiss Med Wkly 2010;140:w13076.
- Lagrange JL, Ramaioli A, Theodore CH, . Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol 2001;9:1313–1319.
- Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol 2007;6:860–868.
- Bekkenk MW, Jansen PM, Meijer CJ, . CD56 + hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004;15: 1097–1108.
- Li T, Zhang B, Ye Y, Yin H. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas. Hum Pathol 2006;37:54–60.
- Chim CS, Ma SY, Au WY, . Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004;1:216–221.
- Avilés A, Neri N, Fernández R, . Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy. Med Oncol 2003;20:13–17.
- Huang Y, de Reyniès A, de Leval L, . Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 2010;115:1226–1237.
- Iqbal J, Weisenburger DD, Chowdhury A, . Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia 2011;25:348–358.
- Ng SB, Selvarajan V, Huang G, . Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling. J Pathol 2011;223:496–510.
- Yamaguchi M, Suzuki R, Kwong YL, . Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016–1020.
- Zhang XX, Xie CH, Xu Y, . Salvage treatment improved survival of patients with relapsed extranodal natural killer/T-cell lymphoma, nasal type. Int J Radiat Oncol Biol Phys 2009;74:747–752.
- Jaccard A, Petit B, Girault S, . L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol 2009;20:110–116.
- Yokoyama H, Yamada MF, Ishizawa K, . Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation. Tohoku J Exp Med 2007;211:395–399.
- Avilés A, Cleto S, Castañeda C, . CMED in the treatment of nasal natural killer cell lymphoma with distant metastases. Hematology 2007;12:241–244.